Sign in

CIK 0001933414

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
841966887
Phone
+1 888-378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-15 Karydas Daphne Director Option exercise 10b5-1 +3,000 $12.02 $36K 9,200
2026-09-15 Karydas Daphne Director Sale 10b5-1 −3,000 $28.58 $86K 6,200
2026-09-15 Karydas Daphne Director Option exercise · Stock Option 10b5-1 −3,000 35,000
2026-06-17 Karydas Daphne Director Option exercise 10b5-1 +3,000 $12.02 $36K 9,200
2026-06-17 Karydas Daphne Director Sale 10b5-1 −3,000 $25.00 $75K 6,200
2026-06-17 Karydas Daphne Director Option exercise · Stock Option 10b5-1 −3,000 38,000
2026-03-31 Karydas Daphne Director Option exercise 10b5-1 +3,000 $12.02 $36K 9,200
2026-03-31 Karydas Daphne Director Sale 10b5-1 −3,000 $25.00 $75K 6,200
2026-03-31 Karydas Daphne Director Option exercise · Stock Option 10b5-1 −3,000 41,000
2026-02-19 Karydas Daphne Director Grant or award +6,200 6,200
2026-02-19 Karydas Daphne Director Grant or award · Stock Option +8,300 8,300
2025-11-13 Karydas Daphne Director Option exercise +15,000 $10.20 $153K 15,000
2025-11-13 Karydas Daphne Director Sale −10,115 $45.81 $463K 4,885
2025-11-13 Karydas Daphne Director Sale −4,885 $46.36 $226K 0
2025-11-13 Karydas Daphne Director Option exercise · Stock Option −15,000 17,900
2025-02-13 Karydas Daphne Director Grant or award · Stock Option +32,900 32,900
2024-05-22 Karydas Daphne Director Grant or award · Stock Option +22,000 22,000
2023-09-13 Karydas Daphne Director Grant or award · Stock Option +44,000 44,000

Page 1 of 1 · 18 trades